Inactive Instrument

Highlights Bioheart, Inc. Other OTC

Equities

US09062F2011

End-of-day quote Other OTC Other stock markets
- ^USD	-

2023	U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
2023	U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	15/23/15	CI
U.S. Stem Cell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/22/10	CI
U.S. Stem Cell, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	24/22/24	CI
U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	01/22/01	CI
U S Stem Cell : Mark Borman appointed Chairman of the Board of USRM	09/22/09	PU
U.S. Stem Cell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	10/21/10	CI
U.S. Stem Cell, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	13/21/13	CI
U.S. Stem Cell, Inc.'s Equity Buyback announced on January 16, 2015, has expired.	31/20/31	CI
U.S. Stem Cell, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	07/19/07	CI
Tranche Update on U.S. Stem Cell, Inc.'s Equity Buyback Plan announced on January 16, 2015.	07/19/07	CI
U.S. Stem Cell, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	08/19/08	CI
Tranche Update on U.S. Stem Cell, Inc.'s Equity Buyback Plan announced on January 16, 2015.	08/19/08	CI
U.S. Stem Cell, Inc. Announces Earnings Results for the First Ended March 31, 2019	08/19/08	CI
Tranche Update on U.S. Stem Cell, Inc.'s Equity Buyback Plan announced on January 16, 2015.	08/19/08	CI
U.S. Stem Cell, Inc. Reports Earnings Results for the Fourth Quarter and Year Ended December 31, 2018	14/19/14	CI
Tranche Update on U.S. Stem Cell, Inc.'s Equity Buyback Plan announced on January 16, 2015.	14/19/14	CI
U.S. Stem Cell, Inc. Announces Revenue Results for the Quarter and Financial Results for the Nine Months Ended September 30, 2018	08/18/08	CI
Tranche Update on U.S. Stem Cell, Inc.'s Equity Buyback Plan announced on January 16, 2015.	08/18/08	CI
U.S. Stem Cell, Inc. Announces Earnings Results for the Second Quarter and Six Months Ending June 30, 2018	09/18/09	CI
Tranche Update on U.S. Stem Cell, Inc.'s Equity Buyback Plan announced on January 16, 2015.	09/18/09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Bioheart, Inc. Other OTC

Equities

US09062F2011

Highlights

Filters